Qureight is an AI platform built for pharmaceutical companies, CROs, and hospitals running clinical studies. It helps speed up analysis for drug trials—especially in lung and heart diseases—by streamlining work with clinical images and biomarkers.
What it does
- Processes clinical imaging and biomarker data to support trial analysis
- Provides a medical image viewer with annotation tools
- Includes built-in AI models to assist with image review and measurement
Who it’s for
- Clinicians reviewing imaging outcomes in studies
- Researchers working on experimental therapies
- Analysts handling large volumes of complex clinical data
Notes on fit and adoption
Compared with general-purpose platforms, Qureight is more specialized around pulmonary and cardiac pathology. It can integrate with medical IT systems, though connecting to older systems may take extra effort. Recent updates expanded image annotation tools and biomarker support, and added more detailed training materials. Teams without prior analytics experience should plan for onboarding and training.
